We first sought to independently confirm the utility of Ang1 and Ang2 levels as functional biomarkers of neonatal sepsis in a cohort of human premature neonates with late-onset sepsis (LOS; onset > 72 hours of age). The gene discussed is ANGPT1; the disease is Sepsis.